Toll-like receptor triggering in systemic sclerosis: time to target

Rheumatology (Oxford). 2023 Feb 6;62(SI):SI12-SI19. doi: 10.1093/rheumatology/keac421.

Abstract

SSc is an autoimmune disease that has features of vascular abnormalities, inflammation and skin and lung fibrosis. Toll-like receptors (TLRs) are sentinel receptors that serve to recognize pathogens or internal danger signals leading to downstream signalling pathways that ultimately lead to inflammation and modification of adaptive immunity. Inflammation and fibrosis appear intricately connected in this disease and TLR ligation on fibroblasts can directly activate these cells to produce copious amounts of collagen, a hallmark of disease. The presence of damage-associated molecular patterns in association with fibrosis has been highlighted. Given their prominent role in disease, this review discusses the evidence of their expression and role in disease pathogenesis and possible therapeutic intervention to mitigate fibrosis.

Keywords: DAMPs; LPS; SSc; cytokines; fibrosis; inflammation; toll-like receptors.

Publication types

  • Review

MeSH terms

  • Fibrosis
  • Humans
  • Inflammation
  • Scleroderma, Systemic*
  • Signal Transduction
  • Toll-Like Receptors*

Substances

  • Toll-Like Receptors